Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peficitinib (ASP015K) + MTX in RA (Phase 2b)
NCT01554696Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of peficitinib in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Started Jul 2012; status: completed.
02
Drugs
peficitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01554696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01554696.